Polypeptide applied to inhibition of intracellular lipid accumulation and synthesis method thereof
US-2024366713-A1 · Nov 7, 2024 · US
Pharmaceutical Composition Comprising MicroRNA-30B, MicroRNA-133A, or MicroRNA-202-5P Inhibitor for Inhibiting Cancer
US2015238564A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2015238564-A1 |
| Application number | US-201514625137-A |
| Country | US |
| Kind code | A1 |
| Filing date | Feb 18, 2015 |
| Priority date | Feb 21, 2014 |
| Publication date | Aug 27, 2015 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided is an anticancer composition, and particularly, a pharmaceutical composition for inhibiting cancer, which includes a microRNA-30b, microRNA-133a, or microRNA-202-5p inhibitor as an active ingredient. The pharmaceutical composition may suppress microRNA-30b, microRNA-133a, or microRNA-202-5p, thereby inhibiting proliferation of cancer cells, and eventually, is expected to be useful for cancer treatment.
First claim
Opening claim text (preview).
What is claimed is: 1 . A method for treating cancer, comprising administering an inhibitor to at least one microRNA selected from the group consisting of microRNA-30b, microRNA-133a, and microRNA-202-5p to a subject. 2 . The method of claim 1 , wherein the microRNA-30b is represented by a base sequence of SEQ. ID. NO: 1. 3 . The method of claim 1 , wherein the microRNA-133a is represented by a base sequence of SEQ. ID. NO: 2.…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
- A61K38/16Primary
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2015238564A1 cover?
- Provided is an anticancer composition, and particularly, a pharmaceutical composition for inhibiting cancer, which includes a microRNA-30b, microRNA-133a, or microRNA-202-5p inhibitor as an active ingredient. The pharmaceutical composition may suppress microRNA-30b, microRNA-133a, or microRNA-202-5p, thereby inhibiting proliferation of cancer cells, and eventually, is expected to be useful for …
- Who is the assignee on this patent?
- Kyungpook Nat Univ Ind Acad
- What technology area does this patent fall under?
- Primary CPC classification A61K38/16. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Aug 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).